• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自一名卵巢乳头状浆液性囊腺癌患者腹水的细胞系的特征分析。

Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.

作者信息

Wilson A P

出版信息

J Natl Cancer Inst. 1984 Mar;72(3):513-21.

PMID:6583437
Abstract

An established cell line derived from the ascites of a patient with serous cystadenocarcinoma of the ovary has been characterized. Features studied included morphology, ultrastructure, clonogenicity in soft agar, population doubling time, karyotype, and chemosensitivity. The results indicated that the cells growing in culture were malignant ovarian tumor cells. These cells retained the ability to form free-floating cysts in culture, which were also present in the original ascitic fluid. The cell line had a chromosome number of 80-92 with no distinct mode and 15 stable markers. At passage 4 the cell line showed resistance to doxorubicin [adriamycin (ADM)], phosphoramide mustard (PM), and cisplatin [cis-dichlorodiammineplatinum(II)] (CIS) but rapidly reverted to CIS sensitivity. At passage 25 the cell line was still resistant to ADM and PM, but by passage 59 sensitivity to these drugs appeared to have increased. Frozen cells from passage 15 onward are available.

摘要

已对源自一名卵巢浆液性囊腺癌患者腹水的既定细胞系进行了特性描述。所研究的特征包括形态学、超微结构、软琼脂中的克隆形成能力、群体倍增时间、核型和化学敏感性。结果表明,培养中生长的细胞是恶性卵巢肿瘤细胞。这些细胞在培养中保留了形成游离漂浮囊肿的能力,原始腹水中也存在这种囊肿。该细胞系的染色体数为80 - 92条,无明显众数,有15个稳定标记。在第4代时,该细胞系对阿霉素[ Adriamycin (ADM)]、磷酰胺氮芥(PM)和顺铂[顺二氯二氨合铂(II)] (CIS)表现出抗性,但迅速恢复对CIS的敏感性。在第25代时,该细胞系仍对ADM和PM有抗性,但到第59代时,对这些药物的敏感性似乎有所增加。从第15代起的冻存细胞可供使用。

相似文献

1
Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.源自一名卵巢乳头状浆液性囊腺癌患者腹水的细胞系的特征分析。
J Natl Cancer Inst. 1984 Mar;72(3):513-21.
2
[Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].[人卵巢腺癌细胞系OC-8611的建立与鉴定]
Zhonghua Zhong Liu Za Zhi. 1989 Nov;11(6):416-8.
3
Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.源自人卵巢浆液性囊腺癌的新建立细胞系HUOA的特性分析
Nihon Sanka Fujinka Gakkai Zasshi. 1987 May;39(5):831-6.
4
Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.源自人卵巢癌腹水的三种新细胞系的建立及鉴定
Gynecol Oncol. 1996 Jul;62(1):82-8. doi: 10.1006/gyno.1996.0194.
5
Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.具有雄激素和雌激素受体的人卵巢癌细胞系(NIH:OVCAR-3)的特征分析。
Cancer Res. 1983 Nov;43(11):5379-89.
6
Characterization of a human ovarian carcinoma cell line: UCI 101.一种人卵巢癌细胞系UCI 101的特性分析。
Gynecol Oncol. 1993 Feb;48(2):203-9. doi: 10.1006/gyno.1993.1034.
7
[Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Sep;37(9):1820-4.
8
A newly established cel line derived from human ovarian adenocarcinoma.一种新建立的源自人卵巢腺癌的细胞系。
Jpn J Exp Med. 1980 Aug;50(4):283-92.
9
Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.经体内组织学分化改变后建立的人卵巢癌肉瘤细胞系的特性分析
Gynecol Oncol. 2001 Dec;83(3):523-32. doi: 10.1006/gyno.2001.6425.
10
[Establishment of a cisplatin-resistant human ovarian cancer cell line and the mechanism of resistance].
Nihon Sanka Fujinka Gakkai Zasshi. 1988 Mar;40(3):379-83.

引用本文的文献

1
Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models.卵巢癌细胞系和同基因模型中的细胞内在铂反应以及相关的遗传和基因表达特征。
bioRxiv. 2024 Jul 29:2024.07.26.605381. doi: 10.1101/2024.07.26.605381.
2
Induces Apoptosis of Human Ovarian Cancer Cells via ATF3-Mediated Regulation of Foxo3a by Tip60.通过 Tip60 介导的 ATF3 对 Foxo3a 的调控诱导人卵巢癌细胞凋亡。
J Microbiol Biotechnol. 2022 Apr 28;32(4):493-503. doi: 10.4014/jmb.2109.09030.
3
Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas.
来源于非浆液性癌的卵巢癌细胞系比来源于高级别浆液性癌的细胞系迁移和侵袭能力更强。
Sci Rep. 2019 Apr 2;9(1):5515. doi: 10.1038/s41598-019-41941-4.
4
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.卵巢癌细胞系的综合基因组、表观基因组和表达分析。
Cell Rep. 2018 Nov 27;25(9):2617-2633. doi: 10.1016/j.celrep.2018.10.096.
5
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.新型高级别浆液性卵巢癌细胞系 OVPA8 的建立与鉴定。
Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080.
6
A Novel Compound ARN-3236 Inhibits Salt-Inducible Kinase 2 and Sensitizes Ovarian Cancer Cell Lines and Xenografts to Paclitaxel.新型化合物ARN-3236抑制盐诱导激酶2并使卵巢癌细胞系和异种移植瘤对紫杉醇敏感。
Clin Cancer Res. 2017 Apr 15;23(8):1945-1954. doi: 10.1158/1078-0432.CCR-16-1562. Epub 2016 Sep 27.
7
Effect of Procyanidin-rich Extract from Natural Cocoa Powder on Cellular Viability, Cell Cycle Progression, and Chemoresistance in Human Epithelial Ovarian Carcinoma Cell Lines.天然可可粉中富含原花青素的提取物对人上皮性卵巢癌细胞系细胞活力、细胞周期进程及化疗耐药性的影响
Pharmacogn Mag. 2016 May;12(Suppl 2):S109-15. doi: 10.4103/0973-1296.182164. Epub 2016 May 11.
8
Assessment of the antitumor potential of Bithionol in vivo using a xenograft model of ovarian cancer.使用卵巢癌异种移植模型评估硫双二氯酚在体内的抗肿瘤潜力。
Anticancer Drugs. 2016 Jul;27(6):547-59. doi: 10.1097/CAD.0000000000000364.
9
The human ovarian cancer cell line CABA I: A peculiar genetic evolution.人卵巢癌细胞系CABA I:一种独特的基因进化
Int J Mol Med. 2016 Apr;37(4):879-88. doi: 10.3892/ijmm.2016.2501. Epub 2016 Feb 25.
10
CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.细胞周期蛋白依赖性激酶5通过调节AKT激活、p21Cip1和p27Kip1介导的G1期细胞周期阻滞及凋亡来调控卵巢癌细胞对紫杉醇的敏感性。
PLoS One. 2015 Jul 6;10(7):e0131833. doi: 10.1371/journal.pone.0131833. eCollection 2015.